Media Search News 03.28.22 FINTEPLA® (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS) Continue Reading 03.07.22 UCB Completes Acquisition of Zogenix, Inc. Continue Reading 03.04.22 Zogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022 Continue Reading 02.28.22 Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results Continue Reading 02.15.22 Zogenix Supports New No-Cost Genetic Testing Program with United Mitochondrial Disease Foundation to Improve Diagnosis of Mitochondrial Diseases Continue Reading 01.19.22 UCB to acquire Zogenix Continue Reading